| 10519126 |
Serine/threonine kinase inhibitors |
James F. Blake, Mark Joseph Chicarelli, Rustam Ferdinand Garrey, John Gaudino, Jonas Grina +6 more |
2019-12-31 |
|
| 9708290 |
Serine/threonine kinase inhibitors |
James F. Blake, Mark Joseph Chicarelli, Rustam Ferdinand Garrey, John Gaudino, Jonas Grina +6 more |
2017-07-18 |
$35,919,000 |
| 9388171 |
Serine/threonine kinase inhibitors |
Jim Blake, Huifen Chen, Mark Joseph Chicarelli, John Gaudino, Lewis Gazzard +4 more |
2016-07-12 |
|
| 9259470 |
Serine/threonine kinase inhibitors |
James F. Blake, Mark Joseph Chicarelli, Rustam Ferdinand Garrey, John Gaudino, Jonas Grina +6 more |
2016-02-16 |
$4,428,000 |
| 8828990 |
N-7 substituted purine and pyrazolopyrimine compounds, compositions and methods of use |
Zhonghua Pei, Joseph P. Lyssikatos, Wendy Lee |
2014-09-09 |
|
| 8697715 |
Serine/threonine kinase inhibitors |
James F. Blake, Mark Joseph Chicarelli, Rustam Ferdinand Garrey, John Gaudino, Jonas Grina +6 more |
2014-04-15 |
$5,723,000 |
| 8486950 |
Janus kinase inhibitor compounds and methods |
Simon Charles Goodacre, Yingjie Lai, Jun Liang, Steven R. Magnuson, Mark S. Stanley +4 more |
2013-07-16 |
|
| 8288381 |
N-9 substituted purine compounds, compositions and methods of use |
Zhonghua Pei, Joseph P. Lyssikatos, Kevin Hon Luen Lau, Wendy Lee |
2012-10-16 |
|
| 8101610 |
Bisamide inhibitors of hedgehog signaling |
Richard Goldsmith, Daniel P. Sutherlin, Alan G. Olivero |
2012-01-24 |
$5,023,000 |
| 7109326 |
Halo-alkoxycarbonyl prodrugs |
Brent Blackburn, Alan G. Olivero |
2006-09-19 |
$118,616,000 |
| 6919369 |
Serine protease inhibitors |
Ignacio Aliagas-Martin, Dean R. Artis, Michael S. DINA, John A. Flygare, Richard Goldsmith +8 more |
2005-07-19 |
$995,788,000 |
| 6472393 |
Serine protease inhibitors |
Ignacio Aliagas-Martin, Dean R. Artis, Michael S. DINA, John A. Flygare, Richard Goldsmith +8 more |
2002-10-29 |
$91,373,000 |
| 5716951 |
Tricyclic inhibitors of the vitronectin receptor |
Brent Blackburn, Todd C. Somers |
1998-02-10 |
$6,194,000 |
| 5705890 |
Tricyclic inhibitors of the GPII.sub.b III.sub.a receptor |
Brent Blackburn, Todd C. Somers |
1998-01-06 |
$5,814,000 |
| 5674863 |
Nonpeptidyl integrin inhibitors having specificity for the GPII.sub.b III.sub.a receptor |
Brent Blackburn, Peter L. Barker, Thomas Gadek, Robert McDowell, Lawrence R. McGee +2 more |
1997-10-07 |
$2,867,000 |
| 5674865 |
Nonpeptidyl integrin inhibitors having specificity for the GPII.sub.b III.sub.a |
Brent Blackburn, Peter L. Barker, Thomas Gadek, Robert McDowell, Lawrence R. McGee +2 more |
1997-10-07 |
$2,867,000 |
| 5663166 |
Nonpeptidyl integrin inhibitors having specificity for the GPII.sub.b III.sub.a receptor |
Brent Blackburn, Peter L. Barker, Thomas Gadek, Robert McDowell, Lawrence R. McGee +2 more |
1997-09-02 |
$3,774,000 |
| 5565449 |
Nonpeptidyl integrin inhibitors having specificity for the GPII.sub.b III.sub.a receptor |
Brent Blackburn, Peter L. Barker, Thomas Gadek, Robert McDowell, Lawrence R. McGee +2 more |
1996-10-15 |
$2,117,000 |
| 5493020 |
Tricyclic inhibitors of the GPII.sub.b III.sub.a receptor |
Brent Blackburn, Todd C. Somers |
1996-02-20 |
$3,990,000 |
